Last $13.78 USD
Change Today -0.06 / -0.43%
Volume 571.3K
IRWD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 5:20 PM 11/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Perry V. Halushka Ph.D., M.D.

Scientific Advisor and Member of Pharmaceuticals Advisory Committee, Ironwood Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Perry V. Halushka,,Ph.D., M.D. serves as Scientific Advisor of Ironwood Pharmaceuticals Inc. Dr. Halushka is the Dean of the College of Graduate Studies and a Professor of Pharmacology and Medicine at the Medical University of South Carolina. A world-renowned clinical pharmacologist, Dr. Halushka is recognized for his research contributions in the role of prostaglandins and thromboxanes in platelet functions and cardiovascular disease. He is a practicing physician and ...

Read Full Background

Corporate Headquarters*

301 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-621-7722
Fax: 617-494-0480

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRWD:US $13.78 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$515.4K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRONWOOD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.